120 related articles for article (PubMed ID: 5435390)
1. [Chemical state and content of radioprotector in some rat tissues at early time-intervals after cystamine administration].
Koshcheenko NN; Filippovich IV; Romantsev EF
Vopr Med Khim; 1970; 16(1):69-72. PubMed ID: 5435390
[No Abstract] [Full Text] [Related]
2. [Comparative study of cystamine conversion in the tissues of white mice and rats].
Tarnopol'skaia LG
Farmakol Toksikol; 1978; 41(1):93-7. PubMed ID: 624396
[TBL] [Abstract][Full Text] [Related]
3. [Chemical transformations of cystamine in mouse tissues].
Golubentsev DA; Titov AV
Vopr Med Khim; 1973; 19(2):177-81. PubMed ID: 4707508
[No Abstract] [Full Text] [Related]
4. [Effect of pharmacologically active agents on the transformation of cystamine in mouse tissues].
Tarnopol'skaia LG
Radiobiologiia; 1982; 22(2):246-50. PubMed ID: 6953525
[No Abstract] [Full Text] [Related]
5. [Intracellular distribution of S35 in the liver and spleen in white mice after administration of S-labelled para-aminoethylisothyuronium, cystamine and 5-mercaptopentylamine disulfide].
Vladimirov VG
Radiobiologiia; 1967; 7(1):71-5. PubMed ID: 5608541
[No Abstract] [Full Text] [Related]
6. [Comparison of the radiation protective effects of cystamine and cysteamine on the skin].
Van Caneghem P
Strahlentherapie; 1969 Feb; 137(2):231-7. PubMed ID: 5822230
[No Abstract] [Full Text] [Related]
7. [Formation and properties of a mixed disulfide of beta-mercaptoethylamine with a partially purified preparation of deoxyribosyltransferase from rat thymus].
Sheremet'evskaia TN; Filippovich IV; Romantsev EF
Vopr Med Khim; 1971; 17(5):540-7. PubMed ID: 5123472
[No Abstract] [Full Text] [Related]
8. [Somatic and genetic lesions after fractionated x-irradiation and an attempt at chemical radiation protection].
Baev IA; Baĭrakova AK; Benova DK
Radiobiologiia; 1974; 14(5):677-80. PubMed ID: 4431911
[No Abstract] [Full Text] [Related]
9. [Catalysis of the oxidation of cysteamine to cystamine by the sulfur-sulfide system].
Scandurra R; Cavallini D
Boll Soc Ital Biol Sper; 1964 Sep; 40(18):1077-80. PubMed ID: 5877343
[No Abstract] [Full Text] [Related]
10. [Species characteristics of cystamine metabolism in mice and rats].
Titov AV; Golubentsev DA; Mikhaĭlova EG
Radiobiologiia; 1974; 14(6):907-9. PubMed ID: 4450001
[No Abstract] [Full Text] [Related]
11. [Adenosine triphosphoric acid pool in rat tissues after the administration of beta-mercaptoethylamine].
Trebenok ZA; Koshcheenko NN; Romantsev EF
Vopr Med Khim; 1980; 26(1):124-6. PubMed ID: 7368617
[TBL] [Abstract][Full Text] [Related]
12. Protection against x-irradiation by sulphdryl compounds. I. Studies on the cellular uptake under various conditions of incubation.
Zwenk H; Vergroesen AJ; Vos O
Int J Radiat Biol Relat Stud Phys Chem Med; 1967; 13(1):69-76. PubMed ID: 5300418
[No Abstract] [Full Text] [Related]
13. [The effect of radioprotectors on the functional state of blood-tissue barriers in animals with limited mobility].
Sabaev VV; Shashkov VS; Sergeev PV; Chistiakov VA; Saĭdametov MA
Kosm Biol Med; 1972; 6(1):7-10. PubMed ID: 4652087
[No Abstract] [Full Text] [Related]
14. [Study of the conditions for the breakdown of mixed disulfides between aminothiol protectors and cell proteins as factors that determine the stability of the disulfide bonds].
Kolina VB; Filippovich IV; Romantsev EF
Vopr Med Khim; 1976; 22(4):528-33. PubMed ID: 1027239
[TBL] [Abstract][Full Text] [Related]
15. [Role of mixed-disulfide bonds in the radioprotective action of beta-mercaptoethylamine (MEA)].
Filippovich IV; Zhulanova ZI; Kolina VB; Mikhaĭlova LP; Sheremet'evskaia TM
Dokl Akad Nauk SSSR; 1972 Jun; 204(4):1006-9. PubMed ID: 5042377
[No Abstract] [Full Text] [Related]
16. [Cysteamine content in mice tissues and in cells of Ehrlich's ascitic carcinoma at the period of its maximal radioprotective action].
Tarasenko AG; Lieh Suan T'u ; Gusareva EV; Graevskiĭ EIa
Dokl Akad Nauk SSSR; 1968; 178(4):951-4. PubMed ID: 5660467
[No Abstract] [Full Text] [Related]
17. [Differences in the accumulation of cystamine in bone marrow cells determined by the nature of the salt-forming anions].
Krasil'nikov II; Levachevskaia EI; Slavachevskaia NM; Tarnopol'skaia LG
Radiobiologiia; 1975; 15(6):902-5. PubMed ID: 176682
[No Abstract] [Full Text] [Related]
18. [Absorption of cystaphos from the gastrointestinal tract and its excretion with urine].
Titov AV
Farmakol Toksikol; 1971; 34(3):330-3. PubMed ID: 5568696
[No Abstract] [Full Text] [Related]
19. Hepatic cysteamine and non-protein sulfhydryl levels following cystamine or cysteamine treatment of galactosamine-poisoned rats.
MacDonald JR; Gandolfi AJ; Sipes IG
Drug Chem Toxicol; 1985; 8(6):483-94. PubMed ID: 4092620
[TBL] [Abstract][Full Text] [Related]
20. [Peculiarities of the accumulation of neutral red in the organs of the mouse at various intervals after the administration of radiation-protective agents].
Zherebchenko PG; Zaĭtseva TG
Radiobiologiia; 1967; 7(1):105-10. PubMed ID: 4305927
[No Abstract] [Full Text] [Related]
[Next] [New Search]
